Replies to post #36015 on RespireRx Pharmaceuticals Inc (fka RSPI)

[sparkyone]

Pete Rose didn't hit many home runs Neuroinv. but he was on base and was a winner, unfortunately he liked to gamble...you know the rest of the story.

We need to get a man on base quickly. The Autism indication is being chased by Seaside.http://www.seasidetherapeutics.com/programs/fragile_x_clinical_trials.php

Varney should be talking to them.

[neuroinv]

The problem is that they don't know which of those subgroups would be the best target--no one does. They can't afford to choose the wrong one.

NeuroInvestment

[neuroinv]

(Partially OT) One last thought: Since I am sure you are looking for anything that would be of benefit to your son: You might keep your eye on Afraxis, a startup that is developing PAK1 inhibitors for Fragile X and autism. Aiming at dendritic spine malformation/ malfunction. Not even in the clinic yet (later this year) but very intriguing. Gary Lynch is on their SAB.

NeuroInvestment